Lalan Wilfong, MD, shares knowledge on how to thrive in the rapidly evolving APM landscape

00:35 •

Lalan Wilfong, MD, shares knowledge on how to thrive in the rapidly evolving APM landscape

Related Videos

Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment

Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment

$Alti Rahman, MHA\MBA, CSSBB, offers advice to oncology practices in today's cancer care landscape$

Alti Rahman, MHA\MBA, CSSBB, offers advice to oncology practices in today's cancer care landscape

Sibel Blau, MD, tells us more about IQ Oncology

Sibel Blau, MD, tells us more about IQ Oncology

Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients

Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients

Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

Jennie Crews, MD, MMM, FACP, explains how to maintain the delivery of quality cancer care

Jennie Crews, MD, MMM, FACP, explains how to maintain the delivery of quality cancer care

Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields

Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields

Jeffrey Patton, MD, recalls barriers to overcome when treating patients with cancer during COVID-19

Jeffrey Patton, MD, recalls barriers to overcome when treating patients with cancer during COVID-19

Sibel Blau, MD, speculates on the role of telehealth in cancer management

Sibel Blau, MD, speculates on the role of telehealth in cancer management

Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients

Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients

Jeff Patton, MD, discusses his new role with the Community Oncology Alliance (COA)

Jeff Patton, MD, discusses his new role with the Community Oncology Alliance (COA)

Ghassan Abou-Alfa, MD, explains how new agents in advanced HCC are being integrated into treatment

Ghassan Abou-Alfa, MD, explains how new agents in advanced HCC are being integrated into treatment

Banu Arun, MD, regarding the optimal setting for PARP inhibitors in breast cancer treatment

Banu Arun, MD, regarding the optimal setting for PARP inhibitors in breast cancer treatment

Matthew I. Milowsky, MD, explains how genomics are changing the way we treat bladder cancer subtypes

Matthew I. Milowsky, MD, explains how genomics are changing the way we treat bladder cancer subtypes

Dan Wygal provides perspective on value-based contracting in oncology

Dan Wygal provides perspective on value-based contracting in oncology

Debra Patt, MD, on why it is important for community oncologists to partner with associations

Debra Patt, MD, on why it is important for community oncologists to partner with associations

Una Hopkins, RN, regarding cancer survivorship resulting from expanded use of immune-oncology agents

Una Hopkins, RN, regarding cancer survivorship resulting from expanded use of immune-oncology agents

Bert O’Neill, MD, on making immunotherapy more effective in mCRC

Bert O’Neill, MD, on making immunotherapy more effective in mCRC

Brad Prechtl tells how his practice is working to improve cancer care

Brad Prechtl tells how his practice is working to improve cancer care